Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 5755 | 24.26 |
09:34 ET | 444 | 24.38 |
09:36 ET | 1390 | 24.29 |
09:38 ET | 300 | 24.3 |
09:39 ET | 900 | 24.37 |
09:41 ET | 4275 | 24.44 |
09:43 ET | 1452 | 24.32 |
09:45 ET | 300 | 24.31 |
09:48 ET | 1300 | 24.29 |
09:50 ET | 400 | 24.26 |
09:52 ET | 300 | 24.26 |
09:54 ET | 1130 | 24.24 |
09:57 ET | 1400 | 24.26 |
09:59 ET | 1019 | 24.26 |
10:01 ET | 5041 | 24.26 |
10:03 ET | 400 | 24.26 |
10:06 ET | 700 | 24.25 |
10:08 ET | 2165 | 24.3 |
10:10 ET | 2840 | 24.28 |
10:12 ET | 2892 | 24.28 |
10:14 ET | 814 | 24.28 |
10:15 ET | 1915 | 24.2875 |
10:17 ET | 120 | 24.28 |
10:19 ET | 700 | 24.31 |
10:21 ET | 2408 | 24.27 |
10:24 ET | 1000 | 24.31 |
10:26 ET | 300 | 24.34 |
10:28 ET | 1995 | 24.29 |
10:30 ET | 1300 | 24.27 |
10:32 ET | 900 | 24.26 |
10:33 ET | 800 | 24.25 |
10:35 ET | 995 | 24.28 |
10:37 ET | 889 | 24.305 |
10:39 ET | 1357 | 24.305 |
10:42 ET | 906 | 24.31 |
10:44 ET | 800 | 24.29 |
10:46 ET | 200 | 24.285 |
10:48 ET | 4126 | 24.27 |
10:50 ET | 300 | 24.26 |
10:51 ET | 1200 | 24.25 |
10:53 ET | 1173 | 24.25 |
10:55 ET | 3452 | 24.23 |
10:57 ET | 2466 | 24.245 |
11:00 ET | 1543 | 24.26 |
11:02 ET | 1832 | 24.28 |
11:04 ET | 700 | 24.27 |
11:06 ET | 2200 | 24.22 |
11:08 ET | 605 | 24.2 |
11:09 ET | 900 | 24.19 |
11:11 ET | 2358 | 24.19 |
11:13 ET | 1125 | 24.17 |
11:15 ET | 679 | 24.17 |
11:18 ET | 100 | 24.17 |
11:20 ET | 200 | 24.175 |
11:22 ET | 600 | 24.173 |
11:24 ET | 2916 | 24.17 |
11:26 ET | 4358 | 24.185 |
11:27 ET | 6100 | 24.15 |
11:29 ET | 1520 | 24.16 |
11:31 ET | 600 | 24.19 |
11:33 ET | 600 | 24.175 |
11:36 ET | 1100 | 24.14 |
11:38 ET | 1858 | 24.11 |
11:40 ET | 10466 | 24.18 |
11:42 ET | 847 | 24.17 |
11:44 ET | 3100 | 24.21 |
11:45 ET | 200 | 24.21 |
11:47 ET | 5384 | 24.2284 |
11:51 ET | 500 | 24.22 |
11:54 ET | 1326 | 24.235 |
11:56 ET | 2992 | 24.24 |
12:00 ET | 4829 | 24.215 |
12:02 ET | 900 | 24.19 |
12:05 ET | 2374 | 24.19 |
12:09 ET | 1785 | 24.215 |
12:12 ET | 1948 | 24.22 |
12:14 ET | 300 | 24.21 |
12:16 ET | 500 | 24.215 |
12:18 ET | 1266 | 24.22 |
12:20 ET | 1200 | 24.22 |
12:21 ET | 1700 | 24.255 |
12:23 ET | 2498 | 24.23 |
12:25 ET | 300 | 24.23 |
12:27 ET | 3400 | 24.22 |
12:30 ET | 11671 | 24.19 |
12:32 ET | 1978 | 24.19 |
12:34 ET | 4840 | 24.19 |
12:36 ET | 2824 | 24.15 |
12:38 ET | 10219 | 24.175 |
12:39 ET | 1807 | 24.16 |
12:41 ET | 375 | 24.16 |
12:43 ET | 2710 | 24.18 |
12:45 ET | 100 | 24.185 |
12:48 ET | 6561 | 24.19 |
12:50 ET | 1000 | 24.185 |
12:52 ET | 6260 | 24.145 |
12:54 ET | 1641 | 24.13 |
12:56 ET | 7640 | 24.14 |
12:57 ET | 2250 | 24.115 |
12:59 ET | 900 | 24.135 |
01:01 ET | 1915 | 24.135 |
01:03 ET | 517 | 24.13 |
01:06 ET | 1321 | 24.14 |
01:08 ET | 495 | 24.145 |
01:10 ET | 6002 | 24.18 |
01:12 ET | 2087 | 24.195 |
01:14 ET | 4112 | 24.21 |
01:15 ET | 682 | 24.23 |
01:17 ET | 5761 | 24.26 |
01:19 ET | 2428 | 24.26 |
01:21 ET | 200 | 24.26 |
01:24 ET | 5754 | 24.23 |
01:26 ET | 1025 | 24.21 |
01:28 ET | 4033 | 24.18 |
01:30 ET | 1668 | 24.195 |
01:32 ET | 847 | 24.18 |
01:33 ET | 2802 | 24.17 |
01:35 ET | 600 | 24.16 |
01:37 ET | 1920 | 24.17 |
01:39 ET | 1719 | 24.195 |
01:42 ET | 2538 | 24.18 |
01:44 ET | 600 | 24.18 |
01:46 ET | 137 | 24.185 |
01:48 ET | 200 | 24.185 |
01:50 ET | 4104 | 24.17 |
01:51 ET | 1817 | 24.18 |
01:53 ET | 967 | 24.18 |
01:55 ET | 1712 | 24.19 |
01:57 ET | 3424 | 24.185 |
02:00 ET | 300 | 24.185 |
02:02 ET | 9199 | 24.19 |
02:04 ET | 3440 | 24.21 |
02:06 ET | 400 | 24.21 |
02:08 ET | 3670 | 24.23 |
02:09 ET | 2943 | 24.2 |
02:11 ET | 1470 | 24.17 |
02:15 ET | 2455 | 24.175 |
02:18 ET | 500 | 24.17 |
02:20 ET | 9749 | 24.155 |
02:22 ET | 3392 | 24.19 |
02:24 ET | 840 | 24.19 |
02:26 ET | 550 | 24.195 |
02:27 ET | 409 | 24.195 |
02:29 ET | 6737 | 24.19 |
02:31 ET | 752 | 24.18 |
02:33 ET | 300 | 24.18 |
02:36 ET | 9483 | 24.225 |
02:38 ET | 1100 | 24.23 |
02:40 ET | 3217 | 24.24 |
02:42 ET | 776 | 24.245 |
02:44 ET | 1200 | 24.25 |
02:45 ET | 4072 | 24.26 |
02:47 ET | 100 | 24.255 |
02:49 ET | 700 | 24.25 |
02:51 ET | 1302 | 24.23 |
02:54 ET | 300 | 24.235 |
02:56 ET | 3792 | 24.22 |
02:58 ET | 2080 | 24.23 |
03:00 ET | 847 | 24.23 |
03:02 ET | 700 | 24.235 |
03:03 ET | 500 | 24.235 |
03:05 ET | 14702 | 24.21 |
03:07 ET | 100 | 24.205 |
03:09 ET | 2455 | 24.19 |
03:12 ET | 6904 | 24.2 |
03:14 ET | 795 | 24.185 |
03:16 ET | 300 | 24.18 |
03:18 ET | 2852 | 24.21 |
03:20 ET | 2348 | 24.24 |
03:21 ET | 4398 | 24.255 |
03:23 ET | 1823 | 24.25 |
03:25 ET | 2100 | 24.245 |
03:27 ET | 3046 | 24.25 |
03:30 ET | 4301 | 24.26 |
03:32 ET | 10931 | 24.23 |
03:34 ET | 2200 | 24.225 |
03:36 ET | 1000 | 24.225 |
03:38 ET | 11131 | 24.205 |
03:39 ET | 1343 | 24.2 |
03:41 ET | 6105 | 24.19 |
03:43 ET | 5031 | 24.16 |
03:45 ET | 18866 | 24.205 |
03:48 ET | 6235 | 24.205 |
03:50 ET | 15935 | 24.215 |
03:52 ET | 16218 | 24.175 |
03:54 ET | 18078 | 24.21 |
03:56 ET | 36094 | 24.155 |
03:57 ET | 34590 | 24.175 |
03:59 ET | 378872 | 24.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.1B | 6.9x | --- |
Exelixis Inc | 6.5B | 34.3x | -21.77% |
P3 Health Partners Inc | 173.6M | -0.8x | --- |
PTC Therapeutics Inc | 2.3B | -4.0x | --- |
Novavax Inc | 1.8B | -4.1x | --- |
Qiagen NV | 9.0B | 27.0x | +12.66% |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.44 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 6.9x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.2x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.